Aquilo Capital Management »

Cytomx Therapeutics shares owned by Aquilo Capital Management

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Aquilo Capital Management from 13F filings

Historical chart of Aquilo Capital Management investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Aquilo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Aquilo Capital Management

Quarter filed Position value Share count Share price at filing
2018-09-30 $13M 675k 18.50
2018-06-30 $15M 650k 22.86

More positions owned by Aquilo Capital Management

SPDR S&P Biotech (XBI)
Merus N V (MRUS)
Loxo Oncology
Fate Therapeutics (FATE)
Aduro Biotech
Synlogic
Cytomx Therapeutics (CTMX)
Pieris Pharmaceuticals
Spero Therapeutics (SPRO)
Xenon Pharmaceuticals (XENE)
Galapagos Nv- (GLPG)
Morphosys (MOR)

View all positions for Aquilo Capital Management

Top funds holding Cytomx Therapeutics

Tang Capital Management
BVF
Vanguard Group
Henderson Group
Acadian Asset Management
Prosight Management
Adage Capital Partners GP
Millennium Management
Jacobs Levy Equity Management
Laurion Capital Management
Schonfeld Strategic Advisors
BlackRock
Renaissance Technologies
Congress Park Capital
Altium Capital Management

View all funds holding Cytomx Therapeutics